Sepsis Screening
Taking a detour
Taking a detour
In the Spring of 2020, we worked together with Advanced Animal Diagnostics to help them understand how they could use their leukocyte differential technology in humans.
In the Spring of 2020, we worked together with Advanced Animal Diagnostics to help them understand how they could use their leukocyte differential technology in humans.
We researched market opportunities and conducted a Voice of Customer campaign to capture their ideas on a point-of-care test for sepsis.
We researched market opportunities and conducted a Voice of Customer campaign to capture their ideas on a point-of-care test for sepsis.
The COVID-19 pandemic occurred mid project and it highlighted the importance of their technology in clinical settings.
The COVID-19 pandemic occurred mid project and it highlighted the importance of their technology in clinical settings.
Our findings are presented on this page.
Our findings are presented on this page.